Our Mission
Our research team at the Maiseyeu Lab at Case Western Reserve University develops nanotechnology tools to improve the therapeutic delivery to challenging disease targets such as the heart and brain. Our focuses include addressing residual risk and plaque resolution in atherosclerosis, improving gene therapy delivery to cardiac tissue, preventing cardiac fibrosis in hypertrophic cardiomyopathy, and improving Alzheimer’s outcomes via immunomodulation. We also have a long-standing interest in toxicology of synthetic and environmental nano-/microparticles and their effects on cardiometabolic health.
Our Vision
Our research team envisions clinically translational research that is practical and effective. We aspire to cure hearts and brains alike.
Lab Core Values
We value innovation, inclusivity, scientific rigor, respect, inter- and intra-lab collaboration, and scientific integrity. We look forward to working with you!